Efficacy of chloroquine plus low-dose primaquine and pyronaridine–artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial

Authors:

Abstract
No abstract available
Funding Information
  • Bill and Melinda Gates Foundation (INV-005898)
  • Bill and Melinda Gates Foundation (INV-048214)
  • President's Malaria Initiative
  • Wellcome Trust (226350/Z/22/Z)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (09150182210039)

This publication has 24 references indexed in Scilit: